Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
The General Medical Council (GMC) has published updated guidance on prescribing, to support doctors who are increasingly seeing patients via remote and virtual consultations.
Good practice in prescribing and managing medicines and devices sets out the regulator’s standards for good practice when prescribing remotely and face to face, when prescribing unlicensed medicines, and for when patient care is shared with another doctor.
The guidance makes clear that the same standards remain when prescribing remotely as they do when seeing a patient face to face, such as being satisfied that an adequate assessment has been made, establishing a dialogue and obtaining the patient’s consent.
Key updates include:
The updated guidance also has specific advice for doctors prescribing remotely with patients in nursing homes or hospices, and patients who are based overseas.
Professor Colin Melville, the GMC’s Medical Director and Director of Education and Standards, said:
“We understand the enormous pressures the profession is under as the pandemic continues and the vaccination programme is rolled out across the UK.
“Our updated guidance supports doctors who are navigating what for many has become a new reality of remote medicine, helping them to maintain good patient care in these incredibly challenging circumstances. It’s vital that the principles of good practice apply, whether a consultation is face to face or remote.”
Dr Caroline Fryar, head of advisory services at the Medical Defence Union (MDU) commented:
“With many consultations moving online during the pandemic, doctors have become even more adept at assessing patients virtually. Prescribing as part of remote consultation is often entirely safe and reasonable as long as the prescribing doctor has enough information about the patient, can make an adequate assessment and have a proper dialogue with the patient.
“However, as ever, doctors need to apply their judgement and remain alert to situations in which a face-to-face consultation may be needed.
“In addition, prescribing to patients overseas presents ethical and legal difficulties for doctors, who need to consider whether they have appropriate registration and indemnity among other considerations.”
The updated guidance, which follows a call for evidence from expert individuals and healthcare organisations between November 2019 and February 2020, will take effect from Monday 5 April, giving doctors and employers six weeks to familiarise themselves with it.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.